Altamira Therapeutics Ltd. (CYTOF) Net income 2018–2024
Altamira Therapeutics Ltd. (CYTOF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.5MFY2024 · since FY2018: -$11.5M → -$8.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$8.5M | -96.4% |
| FY2023 | -$4.3M | +84.5% |
| FY2022 | -$27.8M | — |
| FY2020 | -$8.2M | -23.6% |
| FY2019 | -$6.6M | +42.3% |
| FY2018 | -$11.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice